1st Global Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$593K Sell
7,605
-468
-6% -$35.1K 0.07% 243
2017
Q1
$647K Sell
8,073
-708
-8% -$56.3K 0.08% 219
2016
Q4
$692K Buy
8,781
+134
+2% +$10.4K 0.09% 191
2016
Q3
$674K Buy
8,647
+680
+9% +$49.3K 0.09% 199
2016
Q2
$548K Sell
7,967
-91
-1% -$6.28K 0.08% 226
2016
Q1
$575K Buy
8,058
+605
+8% +$38K 0.08% 216
2015
Q4
$463K Buy
7,453
+216
+3% +$13.2K 0.07% 220
2015
Q3
$410K Buy
7,237
+1,392
+24% +$73.7K 0.07% 241
2015
Q2
$314 Sell
5,845
-478
-8% -$23.3K 0.05% 316
2015
Q1
$300K Buy
6,323
+1,479
+31% +$65.5K 0.04% 338
2014
Q4
$210K Sell
4,844
-2,712
-36% -$111K 0.03% 424
2014
Q3
$260K Buy
7,556
+52
+0.7% +$1.84K 0.04% 344
2014
Q2
$275K Sell
7,504
-56
-0.7% -$1.9K 0.04% 328
2014
Q1
$255K Sell
7,560
-14
-0.2% -$462 0.05% 326
2013
Q4
$257K Buy
7,574
+728
+11% +$25.2K 0.05% 313
2013
Q3
$218K Buy
+6,846
New +$182K 0.04% 342

Other funds holding CMD

1st Global Advisors's CMD Position: Q2 2017 in Review

1st Global Advisors reduced its Cantel Medical Corporation (CMD) stake by 5.8% in Q2 2017, selling an estimated $35.1K and leaving 7,605 shares worth $593K. The position accounts for 0.07% of the portfolio, ranked #243.

1st Global Advisors first reported a position in CMD in Q3 2013 and has held it in 16 quarters since. The position peaked at $692K in Q4 2016. 214 funds tracked by Wall St. Rank hold CMD as of Q2 2017.

  • 1st Global Advisors held 7,605 shares of Cantel Medical Corporation worth $593K as of Q2 2017.
  • 1st Global Advisors sold 468 Cantel Medical Corporation shares in Q2 2017, an estimated $35.1K.
  • Cantel Medical Corporation made up 0.07% of 1st Global Advisors's portfolio in Q2 2017, its #243 holding.
  • 1st Global Advisors first reported a position in Cantel Medical Corporation in Q3 2013 and has held it in 16 quarters since.
  • 1st Global Advisors's Cantel Medical Corporation position peaked at $692K in Q4 2016.
  • 214 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2017.

Based on 1st Global Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.